Tandem Diabetes Care Inc
(LTS:0M0F)
$
32.8
-0.13 (-0.39%)
Market Cap: 2.17 Bil
Enterprise Value: 2.19 Bil
PE Ratio: 0
PB Ratio: 9.19
GF Score: 76/100 Tandem Diabetes Care Inc at Citi Healthcare & Medtech Conference Transcript
Mar 02, 2023 / 07:45PM GMT
Release Date Price:
$36.71
(+1.24%)
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
My back is killing me. But anyway, so I want to talk a little bit about the insulin pump market.
John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director
First of all, hi, Joanne.
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
Hi.
Leigh A. Vosseller
Tandem Diabetes Care, Inc. - Executive VP, CFO & Treasurer
Thank you for having us.
John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director
Good to see all you guys.
Questions & Answers
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
Insulin pump market okay?
John F. Sheridan;Joanne Karen Wuensch
Tandem Diabetes Care, Inc. - President, CEO & Director;Citigroup Inc., Research
Yes, insulin pump market is good.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot